Your browser is no longer supported. Please, upgrade your browser.
Absci Corporation
Index- P/E- EPS (ttm)-4.41 Insider Own8.40% Shs Outstand97.74M Perf Week-27.07%
Market Cap1.01B Forward P/E- EPS next Y-0.76 Insider Trans158.62% Shs Float76.78M Perf Month-53.95%
Income- PEG- EPS next Q-0.19 Inst Own21.55% Short Float2.12% Perf Quarter-
Sales5.43M P/S186.49 EPS this Y-107.20% Inst Trans- Short Ratio3.72 Perf Half Y-
Book/sh-5.68 P/B- EPS next Y49.30% ROA- Target Price- Perf Year-
Cash/sh1.02 P/C10.19 EPS next 5Y15.60% ROE- 52W Range10.21 - 31.53 Perf YTD-51.97%
Dividend- P/FCF- EPS past 5Y- ROI16.60% 52W High-66.86% Beta-
Dividend %- Quick Ratio3.80 Sales past 5Y- Gross Margin- 52W Low2.35% ATR1.80
Employees169 Current Ratio3.80 Sales Q/Q29.10% Oper. Margin- RSI (14)26.67 Volatility12.27% 10.71%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.44 Prev Close10.37
ShortableYes LT Debt/Eq- EarningsSep 07 BMO Payout- Avg Volume437.78K Price10.45
Recom2.60 SMA20-36.17% SMA50-49.57% SMA200-49.57% Volume32,017 Change0.77%
Aug-16-21Initiated Stifel Hold $28
Aug-16-21Initiated Credit Suisse Outperform $40
Aug-16-21Initiated Cowen Market Perform
Aug-16-21Initiated BofA Securities Neutral $26
Sep-22-21 08:00AM  
Sep-21-21 04:59PM  
Sep-20-21 12:28AM  
Sep-13-21 04:05PM  
Sep-10-21 01:15PM  
Sep-09-21 09:23PM  
Sep-07-21 08:30AM  
Jul-26-21 04:00PM  
Jul-21-21 07:03PM  
Absci Corporation, an AI-powered synthetic biology company, offers biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Redmile Group, LLCDirectorJul 26Buy16.001,875,00030,000,0008,031,094Jul 28 09:01 PM
McClain SeanPresident and Chief ExecutiveJul 26Buy16.006009,6006,361,800Jul 28 04:35 PM
MCGINNIS KAREN KDirectorJul 26Buy16.0015,000240,00015,000Jul 28 04:36 PM
Jonasson ZachariahDirectorJul 26Buy16.009,000144,0009,000Jul 28 04:34 PM
Korman SarahGeneral CounselJul 26Buy16.0010,000160,00010,000Jul 28 04:34 PM
Casdin Partners Master Fund, LDirectorJul 26Buy16.001,562,50025,000,0006,745,333Jul 28 04:33 PM
Casdin EliDirectorJul 26Buy16.001,562,50025,000,0006,745,333Jul 28 04:30 PM
Bedrick ToddVP, CCPAOJul 26Buy16.001,00016,0001,000Jul 28 04:29 PM